NIAAA policy for Submission of Applications Containing Genome-Wide Association Studies
The Advisory Panel determined that Genome-Wide Association Studies (GWAS) are currently the preferred approach for the identification of and the confirmation of genes that harbor variants that contribute to AUD, since results from these studies will likely to provide potential insights into translational studies and new therapeutic targets. GWAS can be accomplished with moderate resources and within a short to midrange timeframe.
To achieve the sample sizes needed to detect robust associations with risk for AUD, it will likely be necessary to combine GWAS data across multiple studies into large datasets and to harmonize and use appropriate metrics of alcohol misuse and related phenotypes to ensure comparability across independent analyses.
For additional information, applicants are encouraged to contact the Program Officers or the following individual: